Autor: |
Vladislav Nikulin, Amir Abdullaev, Mikhail Davydov, Alexey Rumyantsev, Vladislav Kirsanov, Elena Bogush, Sergei Tjulandin, Alexandra Tyulyandina |
Rok vydání: |
2020 |
Předmět: |
|
DOI: |
10.21203/rs.3.rs-43656/v1 |
Popis: |
Objective: to demonstrate an efficacy of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in management of malignant ascites (MA) in patients with platinum-refractory ovarian cancer (OC).Background: MA in OC patients can dramatically affect quality of life. HIPEC is an investigational treatment modality that can be effective in MA setting but evidence-based data supporting this method are lacking. Cases presentation: 2 women 50-year-old, FIGO stage IV and 60-year-old, FIGO stage IIIC presented at our center, both had recurrent MA. Patients were treated with HIPEC after platinum-refractory recurrence. The first one had total control of MA with no evidence of disease at the time of last follow-up examination. The 2nd had 9 months of disease control – a relatively long time considering her MA recurrence rate.Conclusions: HIPEC can be successfully used for MA management in selected patients with epithelial OC refractory to standard chemotherapy, however more data are needed from randomized clinical trials. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|